hola1 Strategy Article | Financial News | Digital Look

Aim Bulletin

SkinBioTherapeutics CEO resigns

By Iain Gilbert

Date: Friday 13 Feb 2026

(Sharecast News) - Life science business SkinBioTherapeutics said on Friday that chief executive Stuart Ashman has resigned, having been suspended by the board pending an investigation into matters relating to his conduct.
SkinBioTherapeutics said it was undertaking a full investigation, supported by its professional advisors.

Martin Hunt, non-executive chairman of the group, will assume the role and responsibilities of executive chairman on temporary basis.

The AIM-listed firm has instigated a search to find an interim CEO to appoint as soon as possible, and to find a new, permanent CEO for the longer term.







Reporting by Iain Gilbert at Sharecast.com

Article Archive

Free Membership To Digital Look

Discover the full range of Investor's Tools and Services from Digital Look - voted 'Best Research & Information Provider 2007' by Investors Chronicle.

Click here to see what you have free access to.

Top of Page